Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

Pharmaceutical companies are pushing to disrupt the recently passed Medicare Drug Price Negotiation Program. Learn how AARP is fighting to protect it.

The goal is to make drug prices more in line with European ones. If this were the case, it could result in a massive 24% hit on all firms’ US drug revenue, detrimental to Pfizer.

Successful trial data in a subset of hemophilia patients has set up Pfizer’s Hympavzi, which was approved eight months ago, for a label expansion ...

This article conducts technical analysis and provides forecasts for top trending stocks like Plug Power (PLUG), Uber, and Pfizer (PFE).

Dive into how Donald Trump’s policies on drug pricing may cause European medicine costs to rise, impacting healthcare budgets across the region.

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He has long wanted to more strictly regulate how medicines are promoted.